CD28 co-stimulatory regimes differ in their dependence on phosphatidylinositol 3-kinase: Common co-signals induced by CD80 and CD86

被引:22
|
作者
Cefai, D
Cai, YC
Hu, H
Rudd, C
机构
[1] DANA FARBER CANC INST, DIV TUMOR IMMUNOL, BOSTON, MA 02115 USA
[2] HARVARD UNIV, SCH MED, DEPT PATHOL, BOSTON, MA 02115 USA
[3] HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02115 USA
关键词
D O I
10.1093/intimm/8.10.1609
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD80 (B7-1) and CD86 (B7-2) ligation of CD28 provide co-stimulatory signals required for optimal lymphokine production in response to TCR zeta-CD3 ligation, CD28 binds to several intracellular proteins including phosphatidylinositol 3-kinase (PI3-kinase), the tyrosine kinase ITK and the growth factor receptor-bound protein/Son of Sevenless (GRB-2/SOS) complex, Previously, we showed that TCR zeta-CD3 and CD28 co-stimulation required PI3-kinase binding to the pYMNM motif of the cytoplasmic domain of the co-receptor, In this study, we have investigated whether CD28-associated PI3-kinase is required for CD80 and CD86 co-stimulation, as well as in co-signaling that involves different primary signals (i.e. TCR zeta-CD3 versus phorbol ester/ionomycin), In the presence of anti-CD3, ligation of CD28 by both CD80 and CD86 was found to induce PI3-kinase recruitment and IL-2 production, Furthermore, mutations at Y-191 and M-194 within the pYMNM motif blocked the ability of both ligands to induce IL-2, CD80 and CD86 therefore share a common signaling pathway leading to IL-2 production. By contrast, CD28 mediated co-stimulation involving receptor ligation plus phorbol ester/ionomycin induced IL-2 independent of PI3-kinase binding to CD28, These data indicate that TCR zeta-CD3-dependent CD80 and CD86 co-signaling requires PI3-kinase binding to the CD28pYMNM motif, while phorbol ester and ionomycin can bypass this requirement in CD28 co-stimulation.
引用
收藏
页码:1609 / 1616
页数:8
相关论文
共 50 条
  • [41] Integration of CD28 and CTLA-4 function results in differential responses of T cells to CD80 and CD86
    Manzotti, Claire N.
    Liu, Michael X. P.
    Burke, Fiona
    Dussably, Laure
    Zheng, Yong
    Sansom, David M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (06) : 1413 - 1422
  • [42] 慢性乙型肝炎患者外周血CD80、CD86及其受体CD28的表达
    周永列
    邱莲女
    陈永健
    李洪波
    林惠君
    刘建栋
    检验医学, 2008, (03) : 263 - 267
  • [43] Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28
    William J. Metzler
    Jürgen Bajorath
    William Fenderson
    Shyh-Yu Shaw
    Keith L. Constantine
    Joseph Naemura
    Gina Leytze
    Robert J. Peach
    Thomas B. Lavoie
    Luciano Mueller
    Peter S. Linsley
    Nature Structural Biology, 1997, 4 : 527 - 531
  • [44] The workshop CD28, CD80 and CD86 mAb: Definition of the specificity and functional activity on mixed leucocyte reaction.
    VermotDesroches, C
    Sauvagere, C
    Wijdenes, J
    TISSUE ANTIGENS, 1996, 48 (4-II): : TC202 - TC202
  • [45] Induction of apoptosis in Herpesvirus saimiri-immortalized T lymphocytes by blocking interaction of CD28 with CD80/CD86
    Akari, H
    Fukumori, T
    Iida, S
    Adachi, A
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 263 (02) : 352 - 356
  • [46] T cell co-stimulatory molecules other than CD28
    Watts, TH
    DeBenedette, MA
    CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (03) : 286 - 293
  • [47] CD86 Co-stimulatory Molecule Expression on Cultured Human Endothelial Cells
    Cutolo, Maurizio
    Brizzolara, Renata
    Montagna, Paola
    Soldano, Stefano
    Contini, Paola
    Villaggio, Barbara
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S12 - S12
  • [48] Phorbol esters modulate the coupling of the co-stimulatory molecule CD28 to PI 3-kinase.
    Parry, RV
    Boulougouris, G
    Sansom, D
    Ward, SG
    IMMUNOLOGY, 1996, 89 : AA400 - AA400
  • [49] Antigen receptor triggered upregulation of CD86 and CD80 in human B cells: augmenting role of the CD21/CD19 co-stimulatory complex and IL-4
    Mongini, PKA
    Tolani, S
    Fattah, RJ
    Inman, JK
    CELLULAR IMMUNOLOGY, 2002, 216 (1-2) : 50 - 64
  • [50] T CELL CD80/CD86 CO-STIMULATORY BLOCKADE DOES NOT SUPPRESS CD8 (+) SUBPOPULATION IN THE COURSE OF 48-WEEK TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS
    Murakami, M.
    Ito, M. N.
    Sekiguchi, M.
    Matsui, K.
    Kitano, M.
    Imura, Y.
    Ohmura, K.
    Fujii, T.
    Kuroiwa, T.
    Maeda, K.
    Morita, S.
    Kawahito, Y.
    Mimori, T.
    Sano, H.
    Nishimoto, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 953 - 953